South Africa

 

Mediclinic accepts £3.7bn bid

The board of Mediclinic, the South Africa-based multinational hospital giant, have announced they have agreed acquisition terms with the consortium comprised of Remgro, the investment vehicle of the billionaire Rupert family and a long-time Mediclinic shareholder, and the Mediterranean Shipping Company (MSC). They have recommended these terms to shareholders.

Bid may undervalue Mediclinic

South African analysts say the 504p per share, £3.7bn proposed cash offer for Mediclinic International's equity, the South African, Swiss and Middle East hospital group may somewhat undervalue the business. The current offer equates to an enterprise value of £5.88bn. Analysts put the break up value on an enterprise value at between £5.5bn and £6.2bn. HBI reckons the equity alone could be worth £5.2bn.

HBI 2022: Integrated care is tricky – but worth it

Integrated care is well worth delivering. Not only can it help to break down the silos which get in the way of efficient healthcare delivery, but some very effective tools can only be used with integration. A panel at HBI 2022 asked: What do firms have to consider before they can deliver it?

Mediclinic rejects £3.4bn takeover bid from consortium led by largest shareholder

Multinational South African hospital group Mediclinic has rejected a proposal for a possible cash offer of £3.4bn for the company’s entire share capital. The proposal came from a consortium comprising Mediclinic’s current largest shareholder, South African investment holding firm Remgro, and Mediterranean Shipping Company (MSC), the world’s second largest container shipping provider.

Mediclinic returns to growth in FY22

A strong performance at home saw South African hospital group Mediclinic's revenue grow 8% in the financial year ending March 31, 2022 and its EBITDA margin move up two percentage points to 16%.

South African hospitals recover despite no state support

The South African government made almost no use of private sector capacity during the pandemic, HBI hears, sending less than 100 COVID patients to be treated in the private sector. However, results point to a bounceback for the ‘Big Three’. 

Africa’s healthcare to benefit from projects worth $140m

Two African healthcare improvement projects worth $140m are in the pipeline, one of which could see Africa's first 250-bed single facility specialist hospital in West Africa built. HBI speaks to Dr Egbe Osifo-Dawodu, partner at global healthcare strategic consulting firm Anadach Consulting, to find out more.

Mediclinic stock jumps after a strong six months

Mediclinic, the largest South African hospital group by revenue, saw its shares jump by 7.5% to 346.4p on Friday, after the company reported a “material recovery” in profit margins. This is above the groups previous 2021 high of 344.6p struck in June.

Oxygen shortage concerns in South Africa could lead to stockpiling

Worries of an oxygen shortage in South Africa and concerns about the Delta variant of Covid-19 might lead to operators stockpiling O2 tanks, and has led to them increasing storage tank capacity. HBI talks to a South Africa-based for-profit hospital operator to find out more.

Life Healthcare entering South African imaging market

South African hospital and European imaging group Life Healthcare is planning to enter the imaging market on home turf, with up to 3bn Rand (€180m) earmarked for buying out radiology practices in its hospitals, its head of Investor Relations (IR) tells HBI.

Find Us